A clinical pharmacokinetic drug-drug interaction study between dextromethorphan and emvododstat, a potent anti-SARS-CoV-2 dihydroorotate dehydrogenase inhibitor

PURPOSE: A therapeutic agent that targets both viral replication and the hyper-reactive immune response would offer a highly desirable treatment for severe acute respiratory syndrome corona virus 2 (SARS-CoV-2, coronavirus disease 2019, COVID-19) management. Emvododstat (PTC299; 4-chlorophenyl 6-chl...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Terri L., Laskin, Oscar L., Kaushik, Diksha, Lee, Lucy, Ma, Jiyuan, Bar, Cristian M., Kristensen, Allan, O’Keefe, Kylie, Golden, Lee, Klein, Matthew, Kong, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243242/
https://www.ncbi.nlm.nih.gov/pubmed/37278823
http://dx.doi.org/10.1007/s00228-023-03513-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243242/
https://www.ncbi.nlm.nih.gov/pubmed/37278823
http://dx.doi.org/10.1007/s00228-023-03513-4

Ejemplares similares